Norway Savings Bank held its position in shares of Clorox Company (The) (NYSE:CLX) during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 1,471 shares of the company’s stock at the end of the second quarter. Norway Savings Bank’s holdings in Clorox Company (The) were worth $196,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also made changes to their positions in the stock. American Beacon Advisors Inc. acquired a new position in shares of Clorox Company (The) during the first quarter worth $104,000. Quadrant Capital Group LLC boosted its position in shares of Clorox Company (The) by 23.0% in the first quarter. Quadrant Capital Group LLC now owns 846 shares of the company’s stock worth $106,000 after buying an additional 158 shares during the period. Valley National Advisers Inc. boosted its position in shares of Clorox Company (The) by 0.6% in the first quarter. Valley National Advisers Inc. now owns 860 shares of the company’s stock worth $116,000 after buying an additional 5 shares during the period. Blue Chip Partners Inc. boosted its position in shares of Clorox Company (The) by 0.7% in the first quarter. Blue Chip Partners Inc. now owns 906 shares of the company’s stock worth $122,000 after buying an additional 6 shares during the period. Finally, Zions Bancorporation boosted its position in shares of Clorox Company (The) by 5.6% in the first quarter. Zions Bancorporation now owns 992 shares of the company’s stock worth $134,000 after buying an additional 53 shares during the period. Hedge funds and other institutional investors own 70.75% of the company’s stock.

Clorox Company (NYSE CLX) traded up 0.279% during mid-day trading on Monday, reaching $131.425. 304,144 shares of the company traded hands. Clorox Company has a 52-week low of $111.24 and a 52-week high of $141.76. The firm’s 50-day moving average is $135.88 and its 200 day moving average is $130.94. The stock has a market capitalization of $16.93 billion, a PE ratio of 25.963 and a beta of 0.40.

Clorox Company (The) (NYSE:CLX) last released its quarterly earnings data on Wednesday, May 3rd. The company reported $1.31 EPS for the quarter, topping analysts’ consensus estimates of $1.30 by $0.01. The firm had revenue of $1.48 billion during the quarter, compared to the consensus estimate of $1.48 billion. Clorox Company (The) had a net margin of 11.22% and a return on equity of 215.99%. The firm’s revenue was up 3.6% on a year-over-year basis. During the same quarter in the previous year, the company posted $1.21 earnings per share. On average, equities research analysts expect that Clorox Company will post $5.31 earnings per share for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, August 4th. Shareholders of record on Wednesday, July 19th will be issued a $0.84 dividend. This represents a $3.36 dividend on an annualized basis and a yield of 2.55%. The ex-dividend date of this dividend is Monday, July 17th. This is an increase from Clorox Company (The)’s previous quarterly dividend of $0.80. Clorox Company (The)’s payout ratio is currently 63.12%.

TRADEMARK VIOLATION NOTICE: This piece was reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this piece on another site, it was illegally stolen and reposted in violation of U.S. and international copyright law. The legal version of this piece can be read at https://www.thecerbatgem.com/2017/07/17/norway-savings-bank-holds-stake-in-clorox-company-the-clx.html.

A number of research analysts recently weighed in on the stock. J P Morgan Chase & Co assumed coverage on shares of Clorox Company (The) in a report on Tuesday, March 21st. They issued a “neutral” rating and a $136.00 price objective for the company. Royal Bank Of Canada restated a “hold” rating and issued a $115.00 price objective on shares of Clorox Company (The) in a report on Friday, June 30th. UBS AG restated a “sell” rating and issued a $121.00 price objective (up previously from $117.00) on shares of Clorox Company (The) in a report on Friday, May 5th. Vetr cut shares of Clorox Company (The) from a “buy” rating to a “hold” rating and set a $139.67 price objective for the company. in a report on Tuesday, April 18th. Finally, Citigroup Inc. lifted their price objective on shares of Clorox Company (The) from $75.00 to $76.00 and gave the company a “neutral” rating in a report on Friday, April 7th. Two research analysts have rated the stock with a sell rating, ten have given a hold rating and four have issued a buy rating to the stock. The stock currently has a consensus rating of “Hold” and a consensus target price of $128.26.

Clorox Company (The) Company Profile

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Institutional Ownership by Quarter for Clorox Company (The) (NYSE:CLX)

Receive News & Stock Ratings for Clorox Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Company (The) and related stocks with our FREE daily email newsletter.